nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.71	1	CiPCiCtD
Cytarabine—SLC29A1—Fluorouracil—head and neck cancer	0.103	0.525	CbGbCtD
Cytarabine—ABCC10—Docetaxel—head and neck cancer	0.0601	0.307	CbGbCtD
Cytarabine—SLC22A2—Vinblastine—head and neck cancer	0.0255	0.13	CbGbCtD
Cytarabine—CYP3A4—Vinblastine—head and neck cancer	0.00407	0.0208	CbGbCtD
Cytarabine—CYP3A4—Docetaxel—head and neck cancer	0.00336	0.0171	CbGbCtD
Cytarabine—NT5E—cartilage tissue—head and neck cancer	0.00237	0.0815	CbGeAlD
Cytarabine—POLD1—exocrine gland—head and neck cancer	0.00169	0.058	CbGeAlD
Cytarabine—DCTD—hair follicle—head and neck cancer	0.00158	0.0545	CbGeAlD
Cytarabine—POLD1—mouth—head and neck cancer	0.00126	0.0434	CbGeAlD
Cytarabine—POLD1—neck—head and neck cancer	0.00108	0.0371	CbGeAlD
Cytarabine—DCTD—parotid gland—head and neck cancer	0.000866	0.0298	CbGeAlD
Cytarabine—POLD1—saliva-secreting gland—head and neck cancer	0.000841	0.0289	CbGeAlD
Cytarabine—DCTD—saliva-secreting gland—head and neck cancer	0.000829	0.0285	CbGeAlD
Cytarabine—POLB—lymphoid tissue—head and neck cancer	0.000691	0.0238	CbGeAlD
Cytarabine—DCTD—trachea—head and neck cancer	0.00064	0.022	CbGeAlD
Cytarabine—POLE—saliva-secreting gland—head and neck cancer	0.000629	0.0216	CbGeAlD
Cytarabine—POLB—thyroid gland—head and neck cancer	0.000628	0.0216	CbGeAlD
Cytarabine—NT5E—connective tissue—head and neck cancer	0.00059	0.0203	CbGeAlD
Cytarabine—POLA1—parotid gland—head and neck cancer	0.000566	0.0195	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—head and neck cancer	0.000565	0.0194	CbGeAlD
Cytarabine—NT5E—epithelium—head and neck cancer	0.00056	0.0193	CbGeAlD
Cytarabine—POLB—head—head and neck cancer	0.000557	0.0192	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000552	0.00854	CbGpPWpGaD
Cytarabine—NT5E—Nucleotide metabolism—DPYD—head and neck cancer	0.000532	0.00823	CbGpPWpGaD
Cytarabine—DCTD—Nucleotide metabolism—TYMS—head and neck cancer	0.000528	0.00817	CbGpPWpGaD
Cytarabine—POLD1—thyroid gland—head and neck cancer	0.000513	0.0176	CbGeAlD
Cytarabine—CDA—lymphoid tissue—head and neck cancer	0.000507	0.0174	CbGeAlD
Cytarabine—Gemcitabine—TYMS—head and neck cancer	0.000507	1	CrCbGaD
Cytarabine—DCTD—thyroid gland—head and neck cancer	0.000506	0.0174	CbGeAlD
Cytarabine—DCTD—Nucleotide metabolism—GPX1—head and neck cancer	0.0005	0.00773	CbGpPWpGaD
Cytarabine—NT5E—trachea—head and neck cancer	0.000495	0.017	CbGeAlD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.000488	0.00755	CbGpPWpGaD
Cytarabine—CDA—Nucleotide metabolism—DPYD—head and neck cancer	0.000487	0.00753	CbGpPWpGaD
Cytarabine—POLE—trachea—head and neck cancer	0.000485	0.0167	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000478	0.00739	CbGpPWpGaD
Cytarabine—CDA—thyroid gland—head and neck cancer	0.000461	0.0158	CbGeAlD
Cytarabine—POLD1—head—head and neck cancer	0.000455	0.0157	CbGeAlD
Cytarabine—DCTD—head—head and neck cancer	0.000449	0.0154	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—head and neck cancer	0.000431	0.0148	CbGeAlD
Cytarabine—POLE—lymphoid tissue—head and neck cancer	0.000422	0.0145	CbGeAlD
Cytarabine—POLB—DNA Repair—SMUG1—head and neck cancer	0.000417	0.00645	CbGpPWpGaD
Cytarabine—DCK—Pyrimidine metabolism—TYMS—head and neck cancer	0.000415	0.00642	CbGpPWpGaD
Cytarabine—POLA1—G1/S-Specific Transcription—TYMS—head and neck cancer	0.000401	0.0062	CbGpPWpGaD
Cytarabine—NT5E—thyroid gland—head and neck cancer	0.000392	0.0135	CbGeAlD
Cytarabine—POLB—lymph node—head and neck cancer	0.00039	0.0134	CbGeAlD
Cytarabine—POLE—G1 to S cell cycle control—CCNA1—head and neck cancer	0.000384	0.00594	CbGpPWpGaD
Cytarabine—POLE—thyroid gland—head and neck cancer	0.000384	0.0132	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000383	0.00592	CbGpPWpGaD
Cytarabine—DCK—parotid gland—head and neck cancer	0.000349	0.012	CbGeAlD
Cytarabine—NT5E—head—head and neck cancer	0.000347	0.0119	CbGeAlD
Cytarabine—POLE—head—head and neck cancer	0.00034	0.0117	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—NOTCH1—head and neck cancer	0.000336	0.00519	CbGpPWpGaD
Cytarabine—DCK—saliva-secreting gland—head and neck cancer	0.000334	0.0115	CbGeAlD
Cytarabine—ABCC10—parotid gland—head and neck cancer	0.000332	0.0114	CbGeAlD
Cytarabine—POLA1—thyroid gland—head and neck cancer	0.000331	0.0114	CbGeAlD
Cytarabine—SLC29A1—connective tissue—head and neck cancer	0.000321	0.0111	CbGeAlD
Cytarabine—POLD1—lymph node—head and neck cancer	0.000319	0.011	CbGeAlD
Cytarabine—ABCC10—saliva-secreting gland—head and neck cancer	0.000318	0.0109	CbGeAlD
Cytarabine—DCTD—lymph node—head and neck cancer	0.000314	0.0108	CbGeAlD
Cytarabine—DCK—Purine metabolism—GPX1—head and neck cancer	0.000305	0.00471	CbGpPWpGaD
Cytarabine—NT5E—Nucleotide metabolism—TYMS—head and neck cancer	0.000303	0.00469	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CCNA1—head and neck cancer	0.000302	0.00467	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CEBPA—head and neck cancer	0.000294	0.00455	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CCNA1—head and neck cancer	0.000292	0.00451	CbGpPWpGaD
Cytarabine—NT5E—Nucleotide metabolism—GPX1—head and neck cancer	0.000287	0.00444	CbGpPWpGaD
Cytarabine—CDA—lymph node—head and neck cancer	0.000286	0.00984	CbGeAlD
Cytarabine—DCK—Nucleotide metabolism—DPYD—head and neck cancer	0.000284	0.00439	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CCNA1—head and neck cancer	0.000283	0.00438	CbGpPWpGaD
Cytarabine—CDA—Nucleotide metabolism—TYMS—head and neck cancer	0.000277	0.00429	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CCNA1—head and neck cancer	0.000274	0.00423	CbGpPWpGaD
Cytarabine—SLC29A1—trachea—head and neck cancer	0.00027	0.00928	CbGeAlD
Cytarabine—POLE—G1/S Transition—CCNA1—head and neck cancer	0.000263	0.00407	CbGpPWpGaD
Cytarabine—CDA—Nucleotide metabolism—GPX1—head and neck cancer	0.000263	0.00406	CbGpPWpGaD
Cytarabine—DCK—trachea—head and neck cancer	0.000258	0.00886	CbGeAlD
Cytarabine—POLD1—S Phase—CCNA1—head and neck cancer	0.000248	0.00383	CbGpPWpGaD
Cytarabine—ABCC10—trachea—head and neck cancer	0.000245	0.00844	CbGeAlD
Cytarabine—POLD1—DNA Repair—XRCC1—head and neck cancer	0.000245	0.0038	CbGpPWpGaD
Cytarabine—NT5E—lymph node—head and neck cancer	0.000243	0.00837	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—XRCC1—head and neck cancer	0.00024	0.00371	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCNA1—head and neck cancer	0.000239	0.0037	CbGpPWpGaD
Cytarabine—POLE—lymph node—head and neck cancer	0.000238	0.0082	CbGeAlD
Cytarabine—POLE—DNA Repair—XRCC1—head and neck cancer	0.000237	0.00367	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—head and neck cancer	0.000236	0.00364	CbGpPWpGaD
Cytarabine—SLC29A1—lymphoid tissue—head and neck cancer	0.000235	0.00808	CbGeAlD
Cytarabine—DCTD—Metabolism—UROD—head and neck cancer	0.000231	0.00358	CbGpPWpGaD
Cytarabine—DCK—lymphoid tissue—head and neck cancer	0.000224	0.00772	CbGeAlD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000222	0.00343	CbGpPWpGaD
Cytarabine—ABCC10—lymphoid tissue—head and neck cancer	0.000214	0.00736	CbGeAlD
Cytarabine—SLC29A1—thyroid gland—head and neck cancer	0.000213	0.00734	CbGeAlD
Cytarabine—POLD1—DNA Repair—RAD51—head and neck cancer	0.000213	0.00329	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CCNA1—head and neck cancer	0.000208	0.00321	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—RAD51—head and neck cancer	0.000206	0.00318	CbGpPWpGaD
Cytarabine—POLA1—lymph node—head and neck cancer	0.000205	0.00706	CbGeAlD
Cytarabine—DCK—thyroid gland—head and neck cancer	0.000204	0.00701	CbGeAlD
Cytarabine—NT5E—Differentiation Pathway—VEGFA—head and neck cancer	0.000196	0.00304	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CCNA1—head and neck cancer	0.000195	0.00301	CbGpPWpGaD
Cytarabine—ABCC10—thyroid gland—head and neck cancer	0.000194	0.00668	CbGeAlD
Cytarabine—SLC29A1—head—head and neck cancer	0.000189	0.00651	CbGeAlD
Cytarabine—POLA1—G1/S Transition—CCNA1—head and neck cancer	0.000188	0.0029	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000183	0.00283	CbGpPWpGaD
Cytarabine—DCK—head—head and neck cancer	0.000181	0.00622	CbGeAlD
Cytarabine—POLA1—S Phase—CCNA1—head and neck cancer	0.00017	0.00264	CbGpPWpGaD
Cytarabine—DCK—Nucleotide metabolism—TYMS—head and neck cancer	0.000162	0.0025	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—SMUG1—head and neck cancer	0.00016	0.00247	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000158	0.00245	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—SMUG1—head and neck cancer	0.000154	0.00239	CbGpPWpGaD
Cytarabine—SLC22A1—head—head and neck cancer	0.000154	0.0053	CbGeAlD
Cytarabine—DCK—Nucleotide metabolism—GPX1—head and neck cancer	0.000153	0.00237	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000152	0.00236	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000152	0.00235	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000148	0.00229	CbGpPWpGaD
Cytarabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000147	0.00227	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—UROD—head and neck cancer	0.000133	0.00205	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—head and neck cancer	0.000133	0.00456	CbGeAlD
Cytarabine—POLE—G1/S Transition—TYMS—head and neck cancer	0.000127	0.00197	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000127	0.00196	CbGpPWpGaD
Cytarabine—DCK—lymph node—head and neck cancer	0.000127	0.00436	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—TYMS—head and neck cancer	0.000125	0.00193	CbGpPWpGaD
Cytarabine—CDA—Metabolism—UROD—head and neck cancer	0.000121	0.00188	CbGpPWpGaD
Cytarabine—ABCC10—lymph node—head and neck cancer	0.000121	0.00415	CbGeAlD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000119	0.00184	CbGpPWpGaD
Cytarabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000114	0.00176	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000108	0.00168	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000107	0.00166	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000106	0.00164	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	9.71e-05	0.0015	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	9.63e-05	0.00149	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NAT2—head and neck cancer	9.6e-05	0.00148	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.44e-05	0.00146	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CCND1—head and neck cancer	9.34e-05	0.00144	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—TYMS—head and neck cancer	9.06e-05	0.0014	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	8.43e-05	0.0013	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—DPYD—head and neck cancer	8.42e-05	0.0013	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCNA1—head and neck cancer	8.14e-05	0.00126	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—YAP1—head and neck cancer	7.99e-05	0.00124	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	7.67e-05	0.00119	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	7.67e-05	0.00119	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—TYMS—head and neck cancer	7.63e-05	0.00118	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCNA1—head and neck cancer	7.54e-05	0.00117	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—UROD—head and neck cancer	7.53e-05	0.00117	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	7.46e-05	0.00115	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCNA1—head and neck cancer	7.28e-05	0.00113	CbGpPWpGaD
Cytarabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	7.18e-05	0.00111	CbGpPWpGaD
Cytarabine—DCK—Metabolism—UROD—head and neck cancer	7.08e-05	0.0011	CbGpPWpGaD
Cytarabine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	6.89e-05	0.00107	CbGpPWpGaD
Cytarabine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	6.53e-05	0.00101	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—head and neck cancer	6.15e-05	0.000951	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RAD51—head and neck cancer	6.06e-05	0.000937	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CCND1—head and neck cancer	6.02e-05	0.000931	CbGpPWpGaD
Cytarabine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	6e-05	0.000928	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RAD51—head and neck cancer	5.85e-05	0.000905	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCND1—head and neck cancer	5.81e-05	0.000899	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	5.8e-05	0.000897	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	5.78e-05	0.000895	CbGpPWpGaD
Cytarabine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	5.77e-05	0.000893	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NAT2—head and neck cancer	5.51e-05	0.000853	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	5.46e-05	0.000845	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCND1—head and neck cancer	5.39e-05	0.000834	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCNA1—head and neck cancer	5.19e-05	0.000802	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	5.05e-05	0.000781	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NAT2—head and neck cancer	5.04e-05	0.00078	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	4.92e-05	0.00076	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—DPYD—head and neck cancer	4.83e-05	0.000748	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—TYMS—head and neck cancer	4.8e-05	0.000742	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GSTM1—head and neck cancer	4.74e-05	0.000733	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—YAP1—head and neck cancer	4.59e-05	0.00071	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GPX1—head and neck cancer	4.54e-05	0.000702	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CYP1A1—head and neck cancer	4.49e-05	0.000695	CbGpPWpGaD
Cytarabine—CDA—Metabolism—DPYD—head and neck cancer	4.42e-05	0.000684	CbGpPWpGaD
Cytarabine—CDA—Metabolism—YAP1—head and neck cancer	4.2e-05	0.000649	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RAD51—head and neck cancer	4.17e-05	0.000645	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CCND1—head and neck cancer	4.14e-05	0.00064	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TYMS—head and neck cancer	4.07e-05	0.000629	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	3.95e-05	0.000612	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TYMS—head and neck cancer	3.93e-05	0.000608	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—head and neck cancer	3.84e-05	0.000595	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TYMS—head and neck cancer	3.64e-05	0.000563	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	3.6e-05	0.000557	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TYMS—head and neck cancer	3.51e-05	0.000543	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.39e-05	0.000525	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.22e-05	0.000498	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.15e-05	0.000487	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NAT2—head and neck cancer	3.13e-05	0.000484	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	3.08e-05	0.000477	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NAT2—head and neck cancer	2.94e-05	0.000455	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.93e-05	0.000454	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.91e-05	0.00045	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.81e-05	0.000435	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—UROD—head and neck cancer	2.8e-05	0.000434	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	2.8e-05	0.000433	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMS—head and neck cancer	2.75e-05	0.000426	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DPYD—head and neck cancer	2.74e-05	0.000424	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GSTM1—head and neck cancer	2.72e-05	0.000421	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—head and neck cancer	2.67e-05	0.000413	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—UROD—head and neck cancer	2.61e-05	0.000404	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GPX1—head and neck cancer	2.61e-05	0.000403	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—YAP1—head and neck cancer	2.6e-05	0.000403	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP1A1—head and neck cancer	2.58e-05	0.000399	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DPYD—head and neck cancer	2.58e-05	0.000399	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.54e-05	0.000393	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMS—head and neck cancer	2.52e-05	0.00039	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TYMS—head and neck cancer	2.5e-05	0.000387	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.49e-05	0.000386	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GSTM1—head and neck cancer	2.49e-05	0.000385	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.46e-05	0.00038	CbGpPWpGaD
Cytarabine—DCK—Metabolism—YAP1—head and neck cancer	2.45e-05	0.000379	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.4e-05	0.000371	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GPX1—head and neck cancer	2.38e-05	0.000369	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP1A1—head and neck cancer	2.36e-05	0.000365	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—head and neck cancer	2.33e-05	0.000361	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	2.29e-05	0.000355	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.28e-05	0.000353	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.28e-05	0.000353	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.26e-05	0.00035	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	2.18e-05	0.000337	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	2.08e-05	0.000321	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.05e-05	0.000317	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.02e-05	0.000313	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.98e-05	0.000307	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.98e-05	0.000306	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.92e-05	0.000297	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—head and neck cancer	1.83e-05	0.000283	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—head and neck cancer	1.77e-05	0.000274	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.69e-05	0.000261	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—head and neck cancer	1.64e-05	0.000254	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.63e-05	0.000252	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.62e-05	0.000251	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.61e-05	0.000249	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMS—head and neck cancer	1.56e-05	0.000242	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—head and neck cancer	1.55e-05	0.00024	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.55e-05	0.00024	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTM1—head and neck cancer	1.54e-05	0.000239	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—head and neck cancer	1.54e-05	0.000237	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MAPK3—head and neck cancer	1.51e-05	0.000234	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000229	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—head and neck cancer	1.48e-05	0.000229	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMS—head and neck cancer	1.47e-05	0.000227	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP1A1—head and neck cancer	1.46e-05	0.000227	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MAPK3—head and neck cancer	1.46e-05	0.000226	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTM1—head and neck cancer	1.45e-05	0.000225	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MAPK1—head and neck cancer	1.44e-05	0.000222	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.41e-05	0.000218	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—head and neck cancer	1.4e-05	0.000217	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GPX1—head and neck cancer	1.39e-05	0.000215	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MAPK1—head and neck cancer	1.39e-05	0.000215	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP1A1—head and neck cancer	1.38e-05	0.000213	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—head and neck cancer	1.34e-05	0.000208	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—head and neck cancer	1.34e-05	0.000207	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—head and neck cancer	1.26e-05	0.000195	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—head and neck cancer	1.22e-05	0.000189	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—head and neck cancer	1.21e-05	0.000187	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	1.19e-05	0.000184	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—head and neck cancer	1.17e-05	0.00018	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NAT2—head and neck cancer	1.16e-05	0.00018	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	1.16e-05	0.00018	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.13e-05	0.000175	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.12e-05	0.000173	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	1.11e-05	0.000172	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	1.11e-05	0.000171	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NAT2—head and neck cancer	1.09e-05	0.000168	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.07e-05	0.000166	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.06e-05	0.000164	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK3—head and neck cancer	1.04e-05	0.000161	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DPYD—head and neck cancer	1.02e-05	0.000158	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK1—head and neck cancer	9.89e-06	0.000153	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—YAP1—head and neck cancer	9.69e-06	0.00015	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.57e-06	0.000148	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DPYD—head and neck cancer	9.52e-06	0.000147	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—head and neck cancer	9.44e-06	0.000146	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—UROD—head and neck cancer	9.44e-06	0.000146	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MAPK1—head and neck cancer	9.13e-06	0.000141	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—YAP1—head and neck cancer	9.03e-06	0.00014	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	8.92e-06	0.000138	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—head and neck cancer	8.71e-06	0.000135	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—head and neck cancer	8.64e-06	0.000134	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MAPK1—head and neck cancer	8.51e-06	0.000132	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—head and neck cancer	8.3e-06	0.000128	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—head and neck cancer	8.19e-06	0.000127	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—head and neck cancer	7.72e-06	0.000119	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—head and neck cancer	7.59e-06	0.000117	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—head and neck cancer	7.33e-06	0.000113	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—head and neck cancer	7.14e-06	0.00011	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—head and neck cancer	7.06e-06	0.000109	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—head and neck cancer	6.83e-06	0.000106	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—head and neck cancer	5.82e-06	9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTM1—head and neck cancer	5.75e-06	8.9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GPX1—head and neck cancer	5.51e-06	8.52e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP1A1—head and neck cancer	5.45e-06	8.44e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—head and neck cancer	5.42e-06	8.39e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTM1—head and neck cancer	5.36e-06	8.29e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—head and neck cancer	5.36e-06	8.29e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GPX1—head and neck cancer	5.13e-06	7.94e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP1A1—head and neck cancer	5.08e-06	7.86e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—head and neck cancer	5.04e-06	7.79e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—head and neck cancer	4.38e-06	6.77e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—head and neck cancer	4.12e-06	6.37e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NAT2—head and neck cancer	3.92e-06	6.06e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DPYD—head and neck cancer	3.44e-06	5.32e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—YAP1—head and neck cancer	3.26e-06	5.05e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—head and neck cancer	3.24e-06	5.02e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—head and neck cancer	3.02e-06	4.68e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—head and neck cancer	2.83e-06	4.37e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—head and neck cancer	2.64e-06	4.08e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	2e-06	3.09e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.96e-06	3.03e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.94e-06	2.99e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	1.86e-06	2.88e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.85e-06	2.87e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.84e-06	2.84e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—head and neck cancer	1.63e-06	2.52e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—head and neck cancer	1.52e-06	2.35e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—head and neck cancer	9.52e-07	1.47e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.72e-07	1.04e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—head and neck cancer	5.49e-07	8.49e-06	CbGpPWpGaD
